Učitavanje...
Ticagrelor: The first approved reversible oral antiplatelet agent
Platelet aggregation plays an important role in the pathophysiology of acute coronary syndrome (ACS). Aspirin is the most widely used antiplatelet agent and acts by inhibiting thromboxane A(2)-induced platelet activation. But it does not prevent platelets activation and aggregation by other signalin...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3678676/ https://ncbi.nlm.nih.gov/pubmed/23776835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.112234 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|